reference/15623394

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15623394

Outgoing Links

Predicate	Object
contentType	Journal Article\|Review\|Research Support, Non-U.S. Gov't
endingPage	3439
issn	1742-464X 1742-4658
issueIdentifier	12
pageRange	3422-3439
publicationName	The FEBS Journal
startingPage	3422
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6f6d8aa339ed72296a2e261f2a7299d7
bibliographicCitation	Yamashita F, Kaieda T, Shimomura T, Kawaguchi M, Lin CY, Johnson MD, Tanaka H, Kiwaki T, Fukushima T, Kataoka H. Role of the polycystic kidney disease domain in matriptase chaperone activity and localization of hepatocyte growth factor activator inhibitor-1. FEBS J. 2022 Jun;289(12):3422–39. doi: 10.1111/febs.16348. PMID: 35020274.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9948-0451 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7dff20737de539d93f2e8528a5bdfe83 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ce9a3e16d2b90604ecb882f565757152 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b8b6f41fbf42ce563618e3762e4cf63f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_580cbc361504f47734ce3d9764c9aeda http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6b369ce222a3455267d0d65ccbae654c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db4635673e8699811119efb900efcbf6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_45995d84d3d8c73cff5edebf9dd8811f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f32430114fb712670c516df0f4212b2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d167b8e4797faa259cf5eeb48905034f
date	2022-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1111/febs.16348 https://pubmed.ncbi.nlm.nih.gov/35020274
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32231 https://portal.issn.org/resource/ISSN/1742-464X https://portal.issn.org/resource/ISSN/1742-4658
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Role of the polycystic kidney disease domain in matriptase chaperone activity and localization of hepatocyte growth factor activator inhibitor‐1
discusses	http://id.nlm.nih.gov/mesh/M0283346 http://id.nlm.nih.gov/mesh/M0493685 http://id.nlm.nih.gov/mesh/M0306962 http://id.nlm.nih.gov/mesh/M0019678
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D053491Q000378 http://id.nlm.nih.gov/mesh/D007690Q000378 http://id.nlm.nih.gov/mesh/D012697Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D057809
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0943bfb20a0e8ebccd479b74c7b652df http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b20756cc4b4c3695a07e6f7c0371d02f http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_89d708279e197fec68596fc46bc48c90 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0de30fc5fbcf316e226077ebf13b8b0 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8240

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6768 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6692 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCNP_068813

Total number of triples: 47.